SPOTLIGHT: Baxter: No big legal troubles from heparin

by admin |


Baxter International said it does not expect its high-profile recall of the blood thinner heparin to trigger big legal troubles despite its links to adverse reactions and patient deaths. Report

Suggested Articles

name tag
Pharma

Say hello to Viatris: Pfizer's Upjohn, Mylan merger gets a name

Mylan and Pfizer's Upjohn have a name for their pending merger: Viatris. Heard that before? So has Mylan, which owns a subsidiary with the same name.

by Kyle Blankenship
Test tubes
Pharma

Noninvasive tests can advance NASH diagnostics: analysis

Intercept presented a data analysis that found treatment with Ocaliva led to "early and consistent improvements" in a range of noninvasive tests.

by Amirah Al Idrus
Amarin Vascepa pill
Pharma

FDA panel to scrutinize placebo in Amarin's Vascepa trial

Days before Amarin faces a pivotal FDA vote on its Vascepa expansion, advisors are set to scrutinize the placebo used in its pivotal outcomes trial.

by Kyle Blankenship